Skip to main content
ADBIOTECH Co.,Ltd. logo

ADBIOTECH Co.,Ltd. — Investor Relations & Filings

Ticker · 179530 ISIN · KR7179530001 KO Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2026-05-28 Capital/Financing Update
Country KR South Korea
Listing KO 179530

About ADBIOTECH Co.,Ltd.

http://www.adbiotech.com

ADBIOTECH Co., Ltd. is a biotechnology company specializing in the development and commercialization of immune antibodies. The company's core competency is IgY (Immunoglobulin in Yolk) technology, which utilizes antibodies derived from eggs to create alternatives to conventional vaccines and antibiotics. Its product portfolio targets the livestock, aquaculture, and human health sectors, with applications for disease prevention and treatment in animals like salmon and shrimp, as well as human-focused developments for conditions related to Helicobacter pylori and cholesterol. The company manages the entire value chain from research and development to production and sales. ADBIOTECH is also expanding its technological capabilities into VHH (nanobody) technology, with a strategic focus on the global companion animal market.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 92% confidence The document is a ‘주요사항보고서(전환사채권 발행결정)’ filed with the Financial Services Commission and Korea Exchange, detailing the decision to issue convertible bonds, their terms (principal, interest, maturity, conversion conditions, put‐options, etc.), capital use, underwriting, and related party disclosures. It is a financing activity update announcing the company’s fundraising through bond issuance, matching the definition of a Capital/Financing Update.
2026-05-28 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 92% confidence The document is a Korean ‘주요사항보고서’ (Major Event Report) concerning a third-party allotment capital increase (유상증자 결정) and its multiple corrections. It details the terms of the share issuance, allotment to specific investors, schedules, prices, and corporate governance references for the capital increase decision. This falls squarely under announcements of new share issues or other capital structure changes, matching the Share Issue/Capital Change category.
2026-05-27 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 85% confidence The document is a detailed "주식등의 대량보유상황보고서(약식)" (Large Shareholding Status Report) filed under Korea’s Capital Market Act. It provides specific shareholding amounts, ratios, change reasons, and descriptions of the reporting major shareholder and related parties. This matches the definition of a Major Shareholding Notification (MRQ), not a general announcement or proxy statement. Therefore, it should be classified as MRQ.
2026-05-22 Korean
[기재정정]주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 80% confidence The document is a formal correction notice and convening resolution (“주주총회소집결의”) for an extraordinary shareholders’ meeting, detailing agenda items, director appointments, and business purpose changes – materials provided to shareholders to inform and solicit votes at the meeting. This aligns with Proxy Solicitation & Information Statement (PSI).
2026-05-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a formal notice convening an extraordinary shareholders’ meeting (임시주주총회) including the agenda items (articles amendment and director appointments), voting procedures, outside directors’ activities and compensation, related party transactions, and detailed business overview. It is being sent to shareholders to solicit attendance and votes, which matches the Proxy Solicitation & Information Statement category (PSI).
2026-05-21 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled “의결권 대리행사 권유 참고서류,” which translates to proxy solicitation materials for a shareholders’ meeting, detailing agenda items, voting methods, and candidate information. It is distributed to shareholders to provide information and request votes prior to the meeting, matching the definition of Proxy Solicitation & Information Statement (PSI).
2026-05-21 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.